The week closed with the UK equities edging higher. In London, the FTSE 100 rose 0.5% to finish at 10,224 points, while the FTSE 250 was little changed at 23,253.
The week closed with the UK equities edging higher. In London, the FTSE 100 rose 0.5% to finish at 10,224 points, while the FTSE 250 was little changed at 23,253.
Empire Metals Ltd (AIM: EEE, OTCQX: EPMLF) has provided an update on development work at its Pitfield titanium project in Western Australia, where multiple workstreams are progressing in parallel as
Singer Capital Markets and Stifel on EKF Diagnostics (EKF), following the Group’s trading update which was issued this morning.
Gold prices could climb above $5,100 an ounce in 2026, according to analysts at RBC Capital Markets, who argue the metal’s role as a hedge and portfolio diversifier was further
Empire Metals Limited (AIM: EEE | OTCQX: EPMLF), the AIM-quoted and OTCQX-traded exploration and development company, is pleased to announce that it has entered into a conditional sale and purchase agreement for its 75% interest in
Empire Wins Exploration Discovery of the Year Award
Lift Global Ventures Plc (AQSE:LFT), an investment company focused on financial media, technology and the energy sector, announced the acquisition of shares in IntelliAM Al PLC, the appointment of David Richards
The FTSE 100 closed down 1.1% at 9,698.37 on Friday, as mounting uncertainty over the UK’s public finances triggered a wave of caution across London’s markets.
Empire Metals Limited has begun a diamond drilling campaign at the Thomas prospect within its Pitfield Project in Western Australia, marking the next phase in the company’s exploration and development
Catenai PLC (CTAI), the AIM quoted provider of digital media and technology, announces that, Alludium Ltd will launch its AI Agent collaboration platform at Web Summit in Lisbon from 10-13 November
The FTSE 100 closed firmly lower on Friday, marking one of its steepest one-day declines in a month as renewed US–China trade tensions rattled global markets.
Oxford BioDynamics (OBD), a precision clinical diagnostics company bringing specific and sensitive tests to the practice of medicine based on its EpiSwitch® 3D genomics platform, noted the publication today of “Prostate